Tuesday, April 30, 2019

The U.S. Food and Drug Administration on Friday approved Regeneron Pharmaceuticals Inc's cholesterol drug Praluent as a treatment to cut the risk of heart attacks, stroke and other major cardiovascular events.


from Reuters: Health News https://reut.rs/2UJg6yv

Related Posts:

  • LATEST HEALTH NEWSTwenty-one people aboard a cruise ship that was barred from docking in San Francisco have tested positive for coronavirus, U.S. officials said on Friday, as half a dozen states reported their first cases of the fast-spreading… Read More
  • LATEST HEALTH NEWSKuwait suspended on Saturday all flights to and from Egypt, Lebanon, Syria, Bangladesh, Philippines, India, and Sri-Lanka for a week starting on Saturday, Kuwait's civil aviation directorate said in a tweet. from Reuters… Read More
  • LATEST HEALTH NEWSThe death toll from coronavirus in the United States rose to 12 on Thursday with the latest fatality recorded in King County, Washington, and 53 new cases broke out across the country, striking for the first time in Colorado,… Read More
  • LATEST HEALTH NEWSTravel insurers and travel agents will offer New York residents and businesses the ability to buy coverage that would allow them to cancel a trip for any reason, including those related to coronavirus, New York Governor Andre… Read More
  • LATEST HEALTH NEWSTwenty-one people have tested positive for coronavirus aboard a cruise ship denied entry to San Francisco Bay this week after a number of passengers and crew developed flu-like symptoms on the vessel, which was linked to prev… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner